1. No category

GMMMG Interface Prescribing
Subgroup
Agenda
14th May 2015, 1pm-3pm
HMR CCG
Room 410, Number One Riverside, Smith St. Rochdale OL16 1XU
Declarations of Interest (new declarations only)
Apologies: Lesley Smith, Robert Hallworth
ENC
th
1)
Draft Minutes of 9 April 2015
Item 1
2)
Matters Arising
Item 2c
Item 2e
a) RAG List Recommendations LMWH – now GMMMG approved
b) RAG List Recommendations from February meeting – now GMMMG
approved
c) RAG List Recommendations from March meeting (Drugs for alcohol
dependence, Chapter 3 and 13) – comments received
d) RAG List Recommendations from April meeting (Chapter 1 & 8) – currently
out for comment
e) Ethinylestradiol for pubertal induction
f) Ciclosporin for use in childhood nephrotic syndrome
3)
RAG list review – full review of RAG list now complete
4)
Drugs requiring a review of RAG status
Midodrine
Modafinil on paediatric RAG list – currently AMBER for Sleepiness
associated with narcolepsy
Metformin use in paediatrics
Amiodarone use in paediatrics
5) New Drugs from NTS and Formulary Subgroup Requiring a RAG Status
a) Tiotropium for asthma
b) Ultibro® (Indaceterol/glycopyrronium) inhaler
c) Mysimba® (Naltrexone/bupropion)
6) Progress with GMMMG versions of SCPs
a) Chapter 10 SCP Protocol Review – on hold
b) Chapter 9 SCP Review - hydroxycarbamide
c) Chapter 5 SCP Review - colistimethate for non-CF patients
Item 3
Item 4i
Item 4ii
Item 6
d) Chapter 4 SCP Review
ADHD drugs
Long acting injections
Lithium
Apomorphine
Modafinil
Riluzole
Ketamine (palliative care)
e) Chapter 6 SCP Review
Growth hormone (adults)
Growth hormone(children)
f) Cinacalcet for primary hyperparathyroidism SCP – awaiting GMMMG
approval
g) Ibandronate for breast cancer SCP – awaiting GMMMG approval
h) Domperidone SCP for paediatric use
i)
Chapter 1 SCP review - sulfasalazine
j)
Chapter 8 SCP review
7)
8)
9)
10)
11)
12)
13)
1st draft SCPs for IPS discussion
None this month
Shared Care Protocols for Approval
Denosumab
Shared Care Protocols on GMMMG Website to Archive as of May 2015
Schedule for review of RAG list and associated shared care guidelines
Forward work plan
Inclusion of Grey/DNP List drugs on RAG list
SCP Summary – Appendix to SCP template
14) Timings and Dates of Future IPS meeting
15) Supply of dressings on discharge from secondary care
16) Updates from other groups
a) Formulary Subgroup (verbal)
b) New Therapies Subgroup (verbal)
c) GMMMG (verbal)
17) AOB
Olanzapine pamoate depot injection
Should it be Red not Amber due to 3hr observation period after each dose?
Ondansetron in children
IPS asked to review RAG status and add to Paed RAG list
Date of Next Meeting: 11th June 2015, 1pm-3pm Room 410, HMR CCG,
Number One Riverside, Smith St, Rochdale OL16 1XU
Item 8a
Item 8b
Item 9
Item 10
Item 11
Item 12
Item 13a
Item 13b
Item 13c
Item 14